UBS initiated coverage of Pilgrim's Pride with a Neutral rating and $30 price target. The shares are down 28% year-to-date, but Pilgrim's "poor earnings momentum" into 2026 will prevent a recovery of the stock in the near term, the analyst tells investors in a research note. The firm says stronger poultry production in 2026 in the U.S. and globally, combined with higher corn prices, will drive "material" margin compression at the company.